Lidocaine Hydrochloride Monohydrate has 30 known drug interactions based on U.S. FDA drug labeling data. 30 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Acetaminophen, Acetazolamide, Articaine. Patients taking Lidocaine Hydrochloride Monohydrate should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 30
- Major
- 30
Major (30)
- Lidocaine Hydrochloride Monohydrate + Acetaminophen— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Acetazolamide— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Articaine— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Benzocaine— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Bupivacaine— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Chloroquine— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Cyclophosphamide— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Dapsone— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Flutamide— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Hydroxyurea— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Ifosfamide— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Mepivacaine— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Metoclopramide— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Nitric Oxide— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Nitrofurantoin— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Nitroglycerin— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Nitroprusside— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Nitrous Oxide— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Para-Aminosalicylic Acid— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Phenobarbital— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Phenytoin— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Prilocaine— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Primaquine— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Procaine— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Quinine— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Rasburicase— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Ropivacaine— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Sulfasalazine— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Tetracaine— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Lidocaine Hydrochloride Monohydrate + Valproate Sodium— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.